APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Haemophilus Influenzae Type B Injection Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Haemophilus Influenzae Type B Injection Vaccine Market Analysis and Forecast 2026-2032

Report ID 173996690230 December 2025198 pages

Choose your research edition.

Industry ResearchHaemophilus Influenzae Type B Injection Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilus Influenzae Type B Injection Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Haemophilus Influenzae Type B Injection Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilus Influenzae Type B Injection Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilus Influenzae Type B Injection Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Haemophilus Influenzae Type B Injection Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Haemophilus Influenzae Type B Injection Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Haemophilus Influenzae Type B Injection Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Haemophilus Influenzae Type B Injection Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Haemophilus Influenzae Type B Injection Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Haemophilus Influenzae Type B Injection Vaccine include Bharat Biotech, Biokangtai, Glaxosmithkline, Olymvax, Sanofi Pasteur, Walvax Biotechnology, Beijing Minhai Biotechnology Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd and Chengdu Oulin Biotechnology Co., Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Haemophilus Influenzae Type B Injection Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Haemophilus Influenzae Type B Injection Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Haemophilus Influenzae Type B Injection Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Haemophilus Influenzae Type B Injection Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Haemophilus Influenzae Type B Injection Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Haemophilus Influenzae Type B Injection Vaccine sales, projected growth trends, production technology, application and end-user industry.

Haemophilus Influenzae Type B Injection Vaccine Segment by Company

Bharat Biotech

Biokangtai

Glaxosmithkline

Olymvax

Sanofi Pasteur

Walvax Biotechnology

Beijing Minhai Biotechnology Co., Ltd

Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd

Chengdu Oulin Biotechnology Co., Ltd

Chengdu Institute of Biological Products Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Yuxi Watson Biotechnology Co., Ltd

Haemophilus Influenzae Type B Injection Vaccine Segment by Type

Lyophilized

Non-lyophilized

Haemophilus Influenzae Type B Injection Vaccine Segment by Application

Hospital

Clinic

Haemophilus Influenzae Type B Injection Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus Influenzae Type B Injection Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilus Influenzae Type B Injection Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus Influenzae Type B Injection Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Haemophilus Influenzae Type B Injection Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Haemophilus Influenzae Type B Injection Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Haemophilus Influenzae Type B Injection Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lyophilized Major Manufacturers Table 3. Non-lyophilized Major Manufacturers Table 4. Global Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Haemophilus Influenzae Type B Injection Vaccine Industry Trends Table 8. Haemophilus Influenzae Type B Injection Vaccine Industry Drivers Table 9. Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges Table 10. Haemophilus Influenzae Type B Injection Vaccine Industry Restraints Table 11. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Haemophilus Influenzae Type B Injection Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Haemophilus Influenzae Type B Injection Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Haemophilus Influenzae Type B Injection Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Haemophilus Influenzae Type B Injection Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers, Product Type & Application Table 29. Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Haemophilus Influenzae Type B Injection Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Haemophilus Influenzae Type B Injection Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Haemophilus Influenzae Type B Injection Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Haemophilus Influenzae Type B Injection Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Haemophilus Influenzae Type B Injection Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. Bharat Biotech Company Information Table 57. Bharat Biotech Business Overview Table 58. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 60. Bharat Biotech Recent Development Table 61. Biokangtai Company Information Table 62. Biokangtai Business Overview Table 63. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 65. Biokangtai Recent Development Table 66. Glaxosmithkline Company Information Table 67. Glaxosmithkline Business Overview Table 68. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 70. Glaxosmithkline Recent Development Table 71. Olymvax Company Information Table 72. Olymvax Business Overview Table 73. Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 75. Olymvax Recent Development Table 76. Sanofi Pasteur Company Information Table 77. Sanofi Pasteur Business Overview Table 78. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 80. Sanofi Pasteur Recent Development Table 81. Walvax Biotechnology Company Information Table 82. Walvax Biotechnology Business Overview Table 83. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 85. Walvax Biotechnology Recent Development Table 86. Beijing Minhai Biotechnology Co., Ltd Company Information Table 87. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 88. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 90. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 91. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information Table 92. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview Table 93. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 95. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Development Table 96. Chengdu Oulin Biotechnology Co., Ltd Company Information Table 97. Chengdu Oulin Biotechnology Co., Ltd Business Overview Table 98. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 100. Chengdu Oulin Biotechnology Co., Ltd Recent Development Table 101. Chengdu Institute of Biological Products Co., Ltd Company Information Table 102. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 103. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 105. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 106. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 107. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 108. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 110. Lanzhou Institute of Biological Products Co., Ltd Recent Development Table 111. Yuxi Watson Biotechnology Co., Ltd Company Information Table 112. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 113. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 115. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 116. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 119. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (K Units) Table 120. North America Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 121. North America Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 122. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 125. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (K Units) Table 126. North America Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 127. North America Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 128. North America Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. North America Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 132. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 133. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 134. North America Haemophilus Influenzae Type B Injection Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 135. North America Haemophilus Influenzae Type B Injection Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 136. United States Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 137. Canada Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 138. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 141. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (K Units) Table 142. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 143. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 144. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 147. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (K Units) Table 148. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 149. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 150. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 154. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 155. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 156. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 157. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 158. Germany Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 159. France Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 160. U.K. Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 161. Italy Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 163. China Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 164. China Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 165. China Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 166. China Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (K Units) Table 167. China Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 168. China Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 169. China Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 170. China Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 171. China Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 172. China Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (K Units) Table 173. China Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 174. China Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 176. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 177. Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 178. Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (K Units) Table 179. Asia Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 180. Asia Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 181. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 182. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 183. Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 184. Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (K Units) Table 185. Asia Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 186. Asia Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 187. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 191. Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 192. Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 193. Asia Haemophilus Influenzae Type B Injection Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 194. Asia Haemophilus Influenzae Type B Injection Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Japan Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 196. South Korea Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 197. India Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Australia Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 199. China Taiwan Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 200. Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 201. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 202. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 203. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 204. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (K Units) Table 205. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 206. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 207. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 208. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 209. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 210. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (K Units) Table 211. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 212. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 213. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 215. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 216. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 217. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 218. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 219. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 220. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 221. Brazil Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Argentina Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Chile Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 224. Colombia Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 225. Peru Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 226. Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 227. Israel Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 228. UAE Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Turkey Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 230. Iran Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 231. Egypt Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Table 232. Key Raw Materials Table 233. Raw Materials Key Suppliers Table 234. Haemophilus Influenzae Type B Injection Vaccine Distributors List Table 235. Haemophilus Influenzae Type B Injection Vaccine Customers List Table 236. Research Programs/Design for This Report Table 237. Authors List of This Report Table 238. Secondary Sources Table 239. Primary Sources List of Figures Figure 1. Haemophilus Influenzae Type B Injection Vaccine Image Figure 2. Global Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haemophilus Influenzae Type B Injection Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lyophilized Image Figure 5. Non-lyophilized Image Figure 6. Global Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Haemophilus Influenzae Type B Injection Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Haemophilus Influenzae Type B Injection Vaccine Sales (2021-2032) & (K Units) Figure 16. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Haemophilus Influenzae Type B Injection Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Haemophilus Influenzae Type B Injection Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China Haemophilus Influenzae Type B Injection Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Haemophilus Influenzae Type B Injection Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Haemophilus Influenzae Type B Injection Vaccine Sales Share by Type (2021-2032) Figure 40. North America Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Haemophilus Influenzae Type B Injection Vaccine Sales Share by Application (2021-2032) Figure 42. North America Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Haemophilus Influenzae Type B Injection Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Share by Country (2021-2032) Figure 50. China Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Type (2021-2032) Figure 51. China Haemophilus Influenzae Type B Injection Vaccine Sales Share by Type (2021-2032) Figure 52. China Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Application (2021-2032) Figure 53. China Haemophilus Influenzae Type B Injection Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Haemophilus Influenzae Type B Injection Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Haemophilus Influenzae Type B Injection Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Haemophilus Influenzae Type B Injection Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Haemophilus Influenzae Type B Injection Vaccine Sa

Scope & coverage.

Types
  • Lyophilized
  • Non-lyophilized
Applications
  • Hospital
  • Clinic
Companies covered
  • Bharat Biotech
  • Biokangtai
  • Glaxosmithkline
  • Olymvax
  • Sanofi Pasteur
  • Walvax Biotechnology
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  • Chengdu Oulin Biotechnology Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Lanzhou Institute of Biological Products Co., Ltd
  • Yuxi Watson Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Haemophilus Influenzae Type B Injection Vaccine Market by Type
  3. 1.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lyophilized
  5. 1.2.3 Non-lyophilized
  6. 1.3 Haemophilus Influenzae Type B Injection Vaccine Market by Application
  7. 1.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Haemophilus Influenzae Type B Injection Vaccine Market Dynamics
  1. 2.1 Haemophilus Influenzae Type B Injection Vaccine Industry Trends
  2. 2.2 Haemophilus Influenzae Type B Injection Vaccine Industry Drivers
  3. 2.3 Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges
  4. 2.4 Haemophilus Influenzae Type B Injection Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region
  3. 3.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region
  9. 3.4.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Manufacturers
  6. 4.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Haemophilus Influenzae Type B Injection Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Haemophilus Influenzae Type B Injection Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Haemophilus Influenzae Type B Injection Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Haemophilus Influenzae Type B Injection Vaccine Tier 1, Tier 2, and Tier 3
5 Haemophilus Influenzae Type B Injection Vaccine Market by Type
  1. 5.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type
  2. 5.1.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type
  6. 5.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Haemophilus Influenzae Type B Injection Vaccine Price by Type
6 Haemophilus Influenzae Type B Injection Vaccine Market by Application
  1. 6.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application
  2. 6.1.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application
  6. 6.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Haemophilus Influenzae Type B Injection Vaccine Price by Application
7 Company Profiles
  1. 7.1 Bharat Biotech
  2. 7.1.1 Bharat Biotech Company Information
  3. 7.1.2 Bharat Biotech Business Overview
  4. 7.1.3 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  6. 7.1.5 Bharat Biotech Recent Developments
  7. 7.2 Biokangtai
  8. 7.2.1 Biokangtai Company Information
  9. 7.2.2 Biokangtai Business Overview
  10. 7.2.3 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  12. 7.2.5 Biokangtai Recent Developments
  13. 7.3 Glaxosmithkline
  14. 7.3.1 Glaxosmithkline Company Information
  15. 7.3.2 Glaxosmithkline Business Overview
  16. 7.3.3 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  18. 7.3.5 Glaxosmithkline Recent Developments
  19. 7.4 Olymvax
  20. 7.4.1 Olymvax Company Information
  21. 7.4.2 Olymvax Business Overview
  22. 7.4.3 Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  24. 7.4.5 Olymvax Recent Developments
  25. 7.5 Sanofi Pasteur
  26. 7.5.1 Sanofi Pasteur Company Information
  27. 7.5.2 Sanofi Pasteur Business Overview
  28. 7.5.3 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  30. 7.5.5 Sanofi Pasteur Recent Developments
  31. 7.6 Walvax Biotechnology
  32. 7.6.1 Walvax Biotechnology Company Information
  33. 7.6.2 Walvax Biotechnology Business Overview
  34. 7.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  36. 7.6.5 Walvax Biotechnology Recent Developments
  37. 7.7 Beijing Minhai Biotechnology Co., Ltd
  38. 7.7.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  39. 7.7.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  40. 7.7.3 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  42. 7.7.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  43. 7.8 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  44. 7.8.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information
  45. 7.8.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview
  46. 7.8.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  48. 7.8.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments
  49. 7.9 Chengdu Oulin Biotechnology Co., Ltd
  50. 7.9.1 Chengdu Oulin Biotechnology Co., Ltd Company Information
  51. 7.9.2 Chengdu Oulin Biotechnology Co., Ltd Business Overview
  52. 7.9.3 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  54. 7.9.5 Chengdu Oulin Biotechnology Co., Ltd Recent Developments
  55. 7.10 Chengdu Institute of Biological Products Co., Ltd
  56. 7.10.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  57. 7.10.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  58. 7.10.3 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  60. 7.10.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  61. 7.11 Lanzhou Institute of Biological Products Co., Ltd
  62. 7.11.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  63. 7.11.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  64. 7.11.3 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  66. 7.11.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  67. 7.12 Yuxi Watson Biotechnology Co., Ltd
  68. 7.12.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  69. 7.12.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  70. 7.12.3 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  72. 7.12.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
8 North America
  1. 8.1 North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Type
  2. 8.1.1 North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Haemophilus Influenzae Type B Injection Vaccine Price by Type (2021-2032)
  5. 8.2 North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Application
  6. 8.2.1 North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Haemophilus Influenzae Type B Injection Vaccine Price by Application (2021-2032)
  9. 8.3 North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country
  10. 8.3.1 North America Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Haemophilus Influenzae Type B Injection Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Type
  2. 9.1.1 Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Haemophilus Influenzae Type B Injection Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Application
  6. 9.2.1 Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Haemophilus Influenzae Type B Injection Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Country
  10. 9.3.1 Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Haemophilus Influenzae Type B Injection Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Haemophilus Influenzae Type B Injection Vaccine Market Size by Type
  2. 10.1.1 China Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Haemophilus Influenzae Type B Injection Vaccine Price by Type (2021-2032)
  5. 10.2 China Haemophilus Influenzae Type B Injection Vaccine Market Size by Application
  6. 10.2.1 China Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Haemophilus Influenzae Type B Injection Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Haemophilus Influenzae Type B Injection Vaccine Market Size by Type
  2. 11.1.1 Asia Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Haemophilus Influenzae Type B Injection Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Haemophilus Influenzae Type B Injection Vaccine Market Size by Application
  6. 11.2.1 Asia Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Haemophilus Influenzae Type B Injection Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Haemophilus Influenzae Type B Injection Vaccine Market Size by Country
  10. 11.3.1 Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Haemophilus Influenzae Type B Injection Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Haemophilus Influenzae Type B Injection Vaccine Market Size by Type
  2. 12.1.1 SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Haemophilus Influenzae Type B Injection Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Haemophilus Influenzae Type B Injection Vaccine Market Size by Application
  6. 12.2.1 SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Haemophilus Influenzae Type B Injection Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Haemophilus Influenzae Type B Injection Vaccine Market Size by Country
  10. 12.3.1 SAMEA Haemophilus Influenzae Type B Injection Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Haemophilus Influenzae Type B Injection Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Haemophilus Influenzae Type B Injection Vaccine Value Chain Analysis
  2. 13.1.1 Haemophilus Influenzae Type B Injection Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Haemophilus Influenzae Type B Injection Vaccine Production Mode & Process
  6. 13.2 Haemophilus Influenzae Type B Injection Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Haemophilus Influenzae Type B Injection Vaccine Distributors
  9. 13.2.3 Haemophilus Influenzae Type B Injection Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst